Delivery Order SPE2DB20D2104-SPE2DB24FQ77G
- Not listed
- This federal contract award, valued at $2,283.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LOTREL 10-20 MG CAPSULES 100S. The contract has a firm fixed price of $13,284.40 and an ultimate completion date of September 21, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $9,966.33 firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc., doing business as Amerisourcebergen, holds with the DLA Troop Support Medical. This comprehensive IDC enables Amerisourcebergen to efficiently supply a wide range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LOTREL 10-20 MG CAPSULE 100S. The $3,678.83 firm-fixed-price delivery order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a...
- This federal contract award, valued at $24,361.31, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of 4562241990 - LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, to the DLA. The award is a Firm Fixed Price Delivery Order contract, with a completion date of September 21, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,130.61 Firm Fixed Price Delivery Order contract is for the supply of LOTREL 5-20 MG CAPSULE 100S, a cardiovascular medication. The contract has a completion date of February 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,584.99. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $3,420.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to fulfill the medical supply needs of the DLA Troop Support Medical program. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,749.29 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of LOTREL 10-20 mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The $6,184.11 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ77GDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,198.86 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is a part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. The contract supports the DLA's mission of providing critical medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/17/23 |